4CYTE™ Equine is a revolutionary advancement for horses suffering from osteoarthritis.
Lameness due to joint injury and progressive disease is the most prevalent cause of deteriorating athletic function in performance horses and constitutes a large percentage of the equine practitioner’s caseload. Most joint conditions have the potential to lead to osteoarthritis (OA), which in turn has a poor prognosis for return to normal athletic function. 4CYTE™ Equine brings confidence to a new class of veterinary products. 4CYTE™ Equine is indicated for use when treating mild to moderate OA, after joint damage or surgery.